Evidence map›Paper›PMID 42625867›Full record

ArticleFrontiers in artificial intelligence2026

RN-D

Patrick Salome, Nicolò Cogno, Hoyeon Lee, Gregory Buti, Keyur D Shah, Felix Ehret, Amy Jordan Wisdom, Helen A Shih, Harald Paganetti, Ibrahim Chamseddine

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patrick SalomeDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Nicolò CognoDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Hoyeon LeeDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Gregory ButiDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Keyur D ShahDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Felix EhretDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Amy Jordan WisdomDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Helen A ShihDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Harald PaganettiDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.
Ibrahim ChamseddineDepartment of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, MA, United States.

Funding

Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2021 to 2025
$14.0M
NCI NIH HHS P01 CA261669
6 · The paper itself

Abstract

Purpose: Radiation necrosis (RN) is an important complication of radiation therapy (RT) and is challenging to assess radiographically because lesions are prone to inconsistent delineation, often necessitating intracranial surgery to obtain a diagnosis. This study evaluated how established deep learning segmentation models can be retrained on an institutional RN cohort, assessed external generalization, and integrated the best components into RN-D3, an end-to-end pipeline for RN detection, differentiation, and delineation. Methods and materials: We trained models on a cohort of 52 patients with RN after proton beam RT treated at Massachusetts General Hospital (2004-2016) and tested these models on an external cohort of 29 patients with 39 RN lesions from the MOLAB brain metastasis dataset (photon-based RT, five Spanish institutions, 2005-2021). Six architectures were evaluated: four convolutional neural networks (nnU-Net, STU-Net, TRIAD PlainConv, and Spark3D) and two transformers (SwinUNETR and TRIAD SwinB). Training strategies included training from scratch, supervised pretraining, self-supervised pretraining, and foundation model initialization. Matched-encoder pairs enabled direct comparison of pretraining effects. Performance was evaluated by Dice similarity coefficient (DSC), surface Dice at 2 mm, and lesion detection rate. A post-processing pipeline combining encoder features and shape radiomics was assessed for reducing false positives. The best segmentation model and this classifier were combined into RN-D Results: Spark3D and STU-Net achieved the highest external DSC (median 0.69 [IQR 0.50-0.84] and 0.65 [0.29-0.88]), followed by baseline nnU-Net (0.61 [0.39-0.83]). For Spark3D and STU-Net, large lesions (≥1 mL, Conclusion: RN-D

Indexed as

deep learning segmentationexternal validationfoundation modelspost-contrast MRIradiation necrosis (RN)

Identifiers

PMID42625867
PMCPMC13490108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.